Cite

    Fahrbach, J. et al. (2016). Network meta‐analysis accurately predicted the outcome of a subsequent randomised trial comparing once weekly dulaglutide 1.5 mg and once daily liraglutide 1.8 mg. International journal of clinical practice. 70 (3), pp. 218-221. [Online].